Genomic Study Maps Shared Risk Factors for 14 Psychiatric Disorders
December 14, 2025
Brand Name :
N/A
Synonyms :
ansofaxine
Class :
Antidepressants, Serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRIs)
Pregnancy warnings:
Pregnancy category: N/A
Lactation: Excreted into human milk is unknown
Pregnancy Categories:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
Category B: There were lack of studies on pregnant women and no evidence of risk to the foetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
None
Pharmacodynamics:
None
Pharmacokinetics: None
Absorption
Distribution
Metabolism
Elimination and Excretion
Patient information leaflet
Generic Name: ansofaxine (Pending FDA Approval)
Why do we use ansofaxine?
The main conditions for which ansofaxine is prescribed are major depressive disorder (MDD) and generalized anxiety disorder (GAD).
Because it is an SNRI (serotonin-norepinephrine reuptake inhibitor), it functions by raising the levels of the brain’s neurotransmitters serotonin and norepinephrine.